UBIAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.845800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.481850E-01
Normal-vs-Stage2
2.194100E-02
Normal-vs-Stage3
4.145800E-02
Normal-vs-Stage4
9.578800E-01
Stage1-vs-Stage2
5.458000E-01
Stage1-vs-Stage3
1.677810E-02
Stage1-vs-Stage4
2.723400E-01
Stage2-vs-Stage3
6.952400E-02
Stage2-vs-Stage4
6.216900E-03
Stage3-vs-Stage4
4.056400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.302300E-02
Normal-vs-AfricanAmerican
4.849000E-01
Normal-vs-Asian
1.405030E-01
Caucasian-vs-AfricanAmerican
1.260780E-01
Caucasian-vs-Asian
8.515200E-01
AfricanAmerican-vs-Asian
3.063200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.644200E-03
Normal-vs-Female
1.050010E-01
Male-vs-Female
2.402100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.539600E-01
Normal-vs-Age(41-60Yrs)
6.046500E-02
Normal-vs-Age(61-80Yrs)
2.988400E-02
Normal-vs-Age(81-100Yrs)
2.786400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.178200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.462000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.997200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.409990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.093400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.831000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.803800E-02
Normal-vs-Daily Drinker
3.349600E-02
Normal-vs-Weekly Drinker
6.623600E-02
Normal-vs-Occasional Drinker
2.023400E-01
Normal-vs-Social Drinker
7.533500E-02
Non Drinker-vs-Daily Drinker
3.457200E-01
Non Drinker-vs-Weekly Drinker
6.000400E-01
Non Drinker-vs-Occasional Drinker
9.439800E-02
Non Drinker-vs-Social Drinker
3.523600E-01
Daily Drinker-vs-Weekly Drinker
7.913400E-01
Daily Drinker-vs-Occasional Drinker
3.485800E-01
Daily Drinker-vs-Social Drinker
8.829600E-01
Weekly Drinker-vs-Occasional Drinker
3.320600E-01
Weekly Drinker-vs-Social Drinker
7.286000E-01
Occasional Drinker-vs-Social Drinker
4.965200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.752000E-01
Normal-vs-Grade 2
9.479600E-01
Normal-vs-Grade 3
9.625600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.368400E-01
Grade 1-vs-Grade 3
8.398400E-01
Grade 1-vs-Grade 4
9.752000E-01
Grade 2-vs-Grade 3
7.494400E-01
Grade 2-vs-Grade 4
9.479600E-01
Grade 3-vs-Grade 4
9.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.556400E-02
Normal-vs-NonDiabetic
2.460300E-02
Diabetic-vs-NonDiabetic
8.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.017600E-02
Normal-vs-NoPancreatitis
3.814100E-02
Pancreatitis-vs-NoPancreatitis
1.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.935600E-02
Normal-vs-N1
3.248500E-02
N0-vs-N1
9.088000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.127800E-01
Normal-vs-TP53-NonMutant
1.511190E-01
TP53-Mutant-vs-TP53-NonMutant
3.143800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
